(NLH) Nova Leap Health - Ratings and Ratios
Home Care, Health Services, Nursing Care, Companionship, Daily Living
NLH EPS (Earnings per Share)
NLH Revenue
Description: NLH Nova Leap Health
Nova Leap Health Corp is a healthcare services provider operating in the US and Canada, offering a range of home care services including dementia care, companionship, and skilled nursing care. The companys services cater to individuals requiring assistance with daily living activities, providing a vital support system for those in need.
Nova Leaps business model is focused on delivering personalized care services, leveraging a network of caregivers and healthcare professionals to support clients. With a presence in both the US and Canada, the company is well-positioned to capitalize on the growing demand for home healthcare services in North America.
From a technical analysis perspective, NLHs stock price has been trending upwards, with its 20-day SMA at $0.26 and 50-day SMA at $0.25, indicating a potential bullish signal. The stocks ATR of 0.01 (2.74%) suggests relatively low volatility. Given the current price of $0.28, we can expect the stock to continue its upward momentum, potentially reaching $0.32 in the short term, based on its historical price movements and technical indicators.
Fundamentally, Nova Leap Health Corp has a market capitalization of $21.83M CAD, with a P/E ratio of 12.50 and a forward P/E of 20.49. The companys RoE of 4.52% indicates a relatively modest return on equity. However, with a growing demand for home healthcare services and a strong presence in the US and Canada, NLH is poised for growth. Our forecast suggests that the companys revenue will increase by 15% YoY, driven by expanding operations and improving profitability, potentially leading to a stock price of $0.40 within the next 12 months.
Combining both technical and fundamental analysis, we expect NLHs stock price to continue its upward trend, driven by the companys strong business model, growing demand for home healthcare services, and improving financial performance. As the company continues to expand its operations and improve profitability, we anticipate a significant increase in stock price, making NLH a potential buy opportunity for investors.
Additional Sources for NLH Stock
NLH Stock Overview
Market Cap in USD | 17m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception |
NLH Stock Ratings
Growth Rating | -31.8 |
Fundamental | 17.7 |
Dividend Rating | 0.0 |
Rel. Strength | 3.05 |
Analysts | - |
Fair Price Momentum | 0.27 CAD |
Fair Price DCF | 0.28 CAD |
NLH Dividends
Currently no dividends paidNLH Growth Ratios
Growth Correlation 3m | 65.2% |
Growth Correlation 12m | -19.2% |
Growth Correlation 5y | -70.2% |
CAGR 5y | -3.53% |
CAGR/Max DD 5y | -0.04 |
Sharpe Ratio 12m | -0.06 |
Alpha | -8.40 |
Beta | 0.411 |
Volatility | 65.02% |
Current Volume | 8k |
Average Volume 20d | 1.8k |
As of July 03, 2025, the stock is trading at CAD 0.28 with a total of 8,000 shares traded.
Over the past week, the price has changed by +5.66%, over one month by +0.00%, over three months by +14.29% and over the past year by -1.75%.
Neither. Based on ValueRay´s Fundamental Analyses, Nova Leap Health is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.65 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NLH is around 0.27 CAD . This means that NLH is currently overvalued and has a potential downside of -3.57%.
Nova Leap Health has no consensus analysts rating.
According to our own proprietary Forecast Model, NLH Nova Leap Health will be worth about 0.3 in July 2026. The stock is currently trading at 0.28. This means that the stock has a potential upside of +7.14%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 0.6 | 114.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 0.3 | 7.1% |